TSNM, Procedure Guidelines for Pediatric Bone Imaging with Tc-99m Labeled RAdiopharmaceuticals and F-18 Fluoride 2.0

Tamer Aksoy; Funda Aydın; Gonca Kara Gedik; Nedim Gülaldı; Emel Ceylan Günay; Pelin Özcan Kara; Bilge Volkan Salancı; Pinar Özgen Kıratlı

doi:10.4274/nts.2015.005

PDF

Cite

Request

Guideline

VOLUME: 1 ISSUE: 1

P: 24 - 30

March 2015

TSNM, Procedure Guidelines for Pediatric Bone Imaging with Tc-99m Labeled RAdiopharmaceuticals and F-18 Fluoride 2.0

Nucl Med Semin 2015;1(1):24-30

DOI: 10.4274/nts.2015.005

Bilge Volkan Salancı ⁷

Pinar Özgen Kıratlı ⁷

1. Acibadem Üniversitesi Tip Fakültesi, Nükleer Tip Anabilim Dali, Istanbul, Türkiye

2. Akdeniz Üniversitesi Tip Fakültesi, Nükleer Tip Anabilim Dali, Antalya, Türkiye

3. Selçuk Üniversitesi Tip Fakültesi, Nükleer Tip Anabilim Dali, Konya, Türkiye

4. Dr. Sami Ulus Arastirma Ve Kadin Egitim Hastanesi Ve Çocuk Sagligi Ve Hastaliklari, Nükleer Tip Ünitesi, Ankara, Türkiye

5. Bilim Üniversitesi Tip Fakültesi, Nükleer Tip Anabilim Dali, Istanbul, Türkiye

6. Mersin Üniversitesi Tip Fakültesi, Nükleer Tip Anabilim Dali, Mersin, Türkiye

7. Hacettepe Üniversitesi Tip Fakültesi, Nükleer Tip Anabilim Dali, Ankara, Türkiye

No information available.

No information available

PDF

Cite

Request

ABSTRACT

The purpose of this guideline is to offer nuclear medicine workers helpful information for pediatric bone imaging in daily practice. The guideline includes information and recommendations related to indications, acquisition, processing, and interpretation about Tc-99m labeled diphosphonate bone scintigraphy, as well as some recommendations regarding F-18 fluoride PET.

Keywords:

Pediatrics, bone scintigraphy, F-18 fluoride, guidelines, Tc-99m